Today: 9 April 2026
Ford stock slips in premarket as Tesla delivery miss revives EV demand worries

Ford stock slips in premarket as Tesla delivery miss revives EV demand worries

NEW YORK, January 2, 2026, 09:26 ET — Premarket

  • Ford shares were down about 0.7% before the opening bell, tracking declines in GM and Tesla
  • Tesla’s quarterly deliveries missed estimates, keeping attention on cooling EV demand after the U.S. tax credit ended in September
  • Investors are watching U.S. economic data and the rate outlook as 2026 trading gets underway

Ford Motor’s shares dipped 0.7% in U.S. premarket trading on Friday, ahead of the regular 9:30 a.m. to 4 p.m. session, as weaker-than-expected Tesla delivery data weighed on sentiment across the electric-vehicle space. Reuters

The early move matters because automakers tend to swing with interest-rate expectations and consumer financing costs, and investors are using the first full session of 2026 to reset positions after a late-2025 pullback.

EV demand has been under extra pressure since the Trump administration ended a $7,500 federal tax credit for new electric vehicles at the end of September, lifting effective prices for many models, Reuters reported. Reuters

Ford was last at $13.12, down about 9 cents from its previous close. General Motors fell 1.2% in premarket trading, while Tesla slid 1.1%; Rivian rose 0.7%.

Tesla said it delivered 418,227 vehicles in the October–December quarter, down from 495,570 a year earlier, and below analysts’ expectations of 434,487, according to Visible Alpha. For 2025, Tesla delivered 1.64 million vehicles, compared with 1.79 million in 2024, Reuters reported. Reuters

Rivian, another U.S. EV maker, reported 2025 deliveries of 42,247 vehicles, an 18% decline from a year earlier, and said it will release financial results on Feb. 12 after markets close. The update kept the focus on whether EV makers can defend demand without the expired tax incentive. Reuters

Broader risk appetite was improving ahead of the open, with S&P 500 e-mini futures up about 0.5% in early dealings. Futures are derivatives that track the expected direction of an index before cash trading begins, and investors were also looking ahead to U.S. economic data later Friday and next week’s labor-market reports. Reuters

Still, strategists cautioned investors not to over-read the year’s first sessions. “Bouts of volatility … are likely to remain a feature of equity markets,” Saira Malik, chief investment officer at Nuveen, said. Reuters

Oil prices also eased, with U.S. crude around $56.90 a barrel, extending a slide after steep losses last year. Cheaper fuel can support demand for Ford’s pickup-heavy lineup, but it can also trim one advantage of EVs at the margin. Reuters

For Ford, traders will watch whether weaker EV demand pushes bigger incentives — buyer discounts and rebates — and squeezes industry pricing. Any shift in discounting can ripple into margins just as automakers try to protect cash flow.

Investors are also looking ahead to Ford’s next quarterly update: the company has said it plans to report fourth-quarter and full-year 2025 results on Feb. 10. Guidance for 2026 volumes and costs will be a key catalyst for the stock. Ford From the Road

Stock Market Today

  • Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate
    April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow projections turning positive by 2026. However, actual cash flow remains negative at $501.5 million last year. Investors must weigh DCF optimism against market risks and sector volatility. Ultragenyx scores 4 out of 6 in valuation, indicating some appeal but highlighting areas needing scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:13 AM EDT Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Bank of America stock rises today as Fed-cut bets return and earnings loom
Previous Story

Bank of America stock rises today as Fed-cut bets return and earnings loom

Salesforce (CRM) stock slides 3% today, weighing on Dow as traders eye jobs data and Fed path
Next Story

Salesforce (CRM) stock slides 3% today, weighing on Dow as traders eye jobs data and Fed path

Go toTop